Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version (NCT00119184)Hadassah Medical Organization2002-10-01
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects (NCT01761526)UCB BIOSCIENCES GmbH2002-10-01
Glucose Control in Open Heart Surgery (NCT00370643)University of Sao Paulo2002-10-01
S.T.A.R.S.: Sistas Talking About Real Solutions (NCT01028157)Emory University2002-10-01
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018)University of California, San Francisco2002-10-01
A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects (NCT00602589)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2002-10-01
Clotrimazole Enemas for Pouchitis in Children and Adults (NCT00061282)Web2002-09-30
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia (NCT01020539)Columbia University2002-09-11
Comparison of Two Insulin Aspart Formulations in Healthy Volunteers (NCT01698697)Novo Nordisk A/S2002-09-02
Monoclonal Antibody Treatment for Systemic Lupus Erythematosus (NCT00046774)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2002-09-02
Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00046488)Biogen2002-09-01
BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer (NCT00049244)R-Pharm2002-09-01
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects (NCT00977951)Renovo2002-09-01
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy (NCT00047164)National Institutes of Health Clinical Center (CC)2002-09-01
Clarithromycin 500 mg Tablets Under Fasting Conditions (NCT00835692)Teva Pharmaceuticals USA2002-09-01
Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck (NCT02254018)Boehringer Ingelheim2002-09-01
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer (NCT00052429)Memorial Sloan Kettering Cancer Center2002-09-01
Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer (NCT00283829)University of Washington2002-09-01
Study of NS-9 in Patients With Liver Metastases (NCT00094003)NS Pharma, Inc.2002-09-01
Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever (NCT00063089)Nabi Biopharmaceuticals2002-09-01
Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT00049387)National Cancer Institute (NCI)2002-09-01
Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device (NCT01356212)Egalet Ltd2002-09-01
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer (NCT00581971)University of Alabama at Birmingham2002-09-01
Effects of Lateral Trunk Support on Spinal Alignment in Spinal Cord Injured Persons (NCT00154505)National Taiwan University Hospital2002-09-01
Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg (NCT00650286)Mylan Pharmaceuticals Inc2002-09-01
Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects (NCT02273544)Boehringer Ingelheim2002-09-01
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00049283)National Cancer Institute (NCI)2002-09-01
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation (NCT00052520)Fred Hutchinson Cancer Center2002-09-01
Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02227901)National Cancer Institute (NCI)2002-09-01
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. (NCT00423566)University of Oxford2002-09-01
Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant (NCT00052598)Fred Hutchinson Cancer Center2002-09-01
Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX) (NCT00233766)Cordis US Corp.2002-09-01
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects. (NCT00847795)Renovo2002-09-01
Marijuana for Cancer Pain (NCT00046709)Center for Medicinal Cannabis Research2002-09-01
Endometriosis : Traditional Medicine vs Hormone Therapy (NCT00034047)National Center for Complementary and Integrative Health (NCCIH)2002-09-01
Azithromycin 600 Mg Tablets, Fasting (NCT00834756)Teva Pharmaceuticals USA2002-09-01
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions (NCT01282801)Teva Pharmaceuticals USA2002-09-01
Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer (NCT00047710)M.D. Anderson Cancer Center2002-09-01
To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions (NCT00946686)Sandoz2002-09-01
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963)National Cancer Institute (NCI)2002-09-01
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions (NCT01260896)Teva Pharmaceuticals USA2002-09-01
Comparability DE vs CD-CHO1 (NCT00277199)Bristol-Myers Squibb2002-09-01
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00052338)National Cancer Institute (NCI)2002-09-01
Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) (NCT00285584)NYU Langone Health2002-09-01
Infusional C-myb ASODN in Advanced Hematologic Malignancies (NCT00780052)Abramson Cancer Center at Penn Medicine2002-09-01
To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol (NCT01478490)Astellas Pharma Inc2002-09-01
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism (NCT00282412)Northwestern University2002-09-01
Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders (NCT00278642)Richard Burt, MD2002-09-01
Hyperalgesia in Methadone Patients: Can it be Treated? (NCT00333242)National Institute on Drug Abuse (NIDA)2002-09-01
Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions (NCT00840411)Teva Pharmaceuticals USA2002-09-01
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT00049582)National Cancer Institute (NCI)2002-09-01
Metro Atlanta Heart Disease Study - II (MAHDS II) (NCT01235702)Morehouse School of Medicine2002-09-01
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus (NCT00552227)Chromaderm, Inc.2002-09-01
Phase I Trial of Smallpox Vaccine (NCT00046397)National Institute of Allergy and Infectious Diseases (NIAID)2002-09-01
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants (NCT00056875)University of Michigan2002-09-01
Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State (NCT01562587)Novo Nordisk A/S2002-09-01
IPTi in Mozambican Infants for Malaria Prevention (NCT00209794)Hospital Clinic of Barcelona2002-09-01
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides (NCT00052377)National Cancer Institute (NCI)2002-09-01
ITV Extension Study (NCT00332930)Kirby Institute2002-09-01
Diabetes Management Personal Trainer (NCT00340093)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2002-08-23
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions (NCT01131936)Dr. Reddy's Laboratories Limited2002-08-01
IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer (NCT00234416)AstraZeneca2002-08-01
Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression (NCT01282632)Sunnybrook Health Sciences Centre2002-08-01
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer (NCT00049101)Memorial Sloan Kettering Cancer Center2002-08-01
HIV-1 Vaccine Test in Uninfected Adult Volunteers (NCT00045838)National Institute of Allergy and Infectious Diseases (NIAID)2002-08-01
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00047047)National Cancer Institute (NCI)2002-08-01
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma (NCT00416923)University of California, San Francisco2002-08-01
Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People (NCT00543647)Solvay Pharmaceuticals2002-08-01
Rapamycin vs Methotrexate in Diffuse SSc (NCT00241189)University of California, Los Angeles2002-08-01
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer (NCT00047307)National Cancer Institute (NCI)2002-08-01
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors (NCT00044785)Wellstat Therapeutics2002-08-01
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions. (NCT00840216)Teva Pharmaceuticals USA2002-08-01
Study of Adjuvant Radiochemotherapy for Gastric Cancer (NCT00188266)University Health Network, Toronto2002-08-01
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix (NCT00129428)University of Michigan2002-08-01
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1 (NCT00051896)National Institute on Drug Abuse (NIDA)2002-08-01
Clofarabine in Adult Patients With Advanced Solid Tumors (NCT00125840)Genzyme, a Sanofi Company2002-08-01
Gene Therapy to Improve Wound Healing in Patients With Diabetes (NCT00065663)Tissue Repair Company2002-08-01
UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00042861)National Cancer Institute (NCI)2002-08-01
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate (NCT02361125)M.D. Anderson Cancer Center2002-08-01
Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers (NCT02183012)Boehringer Ingelheim2002-08-01
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma (NCT00052442)Spectrum Pharmaceuticals, Inc2002-08-01
Pharmacokinetic Evaluation of Testosterone Gel (1%) (NCT00193700)Solvay Pharmaceuticals2002-08-01
Trial of Impact of Crime Group Intervention for Jail Inmates (NCT01380977)George Mason University2002-08-01
Safety Study of NHL With 90Y-hLL2 IgG (NCT00421395)Gilead Sciences2002-08-01
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions (NCT00654277)Par Pharmaceutical, Inc.2002-08-01
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110)National Cancer Institute (NCI)2002-08-01
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (NCT00489164)Cordis US Corp.2002-08-01
Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer (NCT00058045)Roswell Park Cancer Institute2002-08-01
Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions (NCT00841659)Teva Pharmaceuticals USA2002-08-01
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers (NCT00254865)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2002-08-01
BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling (NCT00252213)Mayo Clinic2002-08-01
E7389 in Treating Patients With Advanced Solid Tumors (NCT00047034)National Cancer Institute (NCI)2002-08-01
Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition (NCT01888341)Dr. Reddy's Laboratories Limited2002-08-01
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions (NCT00840840)Teva Pharmaceuticals USA2002-08-01
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions (NCT00653458)Par Pharmaceutical, Inc.2002-08-01
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction (NCT00047346)National Cancer Institute (NCI)2002-08-01
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00052559)National Cancer Institute (NCI)2002-08-01
Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer (NCT00043823)M.D. Anderson Cancer Center2002-08-01
Effect of Leg Strengthening Exercise After Hip Fracture (NCT00997776)Arcadia University2002-08-01
Bioavailability Study of Metronidazole Capsules Under Fasting Conditions (NCT01380509)Par Pharmaceutical, Inc.2002-08-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.